World adc san diego 2024
Access Our Scientific Posters
| Read Poster |
| Read Poster |
Our Services
Target Selection Challenges
We use NGS/AI-based TAA discovery and selection, patient-derived tumor/normal tissue biobanks, organoids, and PDX models, with integrated bioinformatics and biomarker discovery.
Antibody Generation Complexity
Comprehensive antibody generation services, including antigen layout and production, hybridoma generation, antibody screening (binding, ADCC, internalization), and deep phase screening for command optimization. We also offer petite molecule integration to enhance the therap
The World’s Largest & Definitive Antibody-Drug Conjugate Event
As antibody-drug conjugates aspire to advance to earlier-line treatments, harnessing innovation has never been more important to redefine the oncology standard of nurture and provide long-term benefit to patients.
Returning as the annual touchpoint for the global community, the 16th World ADC San Diego is THE week to fully immerse yourself in all things antibody-drug conjugate, spotlighting the cutting-edge innovation empowering the industry to develop differentiated ADCs that show remove advantages against standard-of-care therapies with clinically meaningful patient benefit.
With 7 streams of end-to-end content spanning discovery chemistry, discovery biology, preclinical, translational medicine, clinical lessons, process and analytical development, and manufacturing and supply chain: this is your one-stop bioconjugate shop to bring your team up to speed with ADC fundamentals, receive answers to the problems hindering your ADC R&D, and distinguish emerging trends to ensure you stay ahead of the curve.
Providing unparalleled networking opportunities with 1,400+ attendees from start-u
World ADC San Diego 2024: A recap of the latest breakthroughs and innovations in ADC development
World ADC San Diego 2024, the premier event for the antibody-drug conjugate (ADC) community, was held at the beginning of November. This global conference brought together leading researchers, biopharma companies, and service providers to discuss the latest breakthroughs, strategies, and innovations in ADC development.
The conference brings together over 1,500 experts in cancer biology, medicinal chemistry, and drug manufacturing to share recent findings and collaborate on the next generation of ADCs. Our team was thrilled to attend this year’s event, engaging with the scientific community to accelerate the most promising technology for cancer treatment to date.
Moments of Note: Genentech’s Presentation, TME-Targeting and New Conjugation Techniques
This year featured over 100 posters and presentations on topics ranging from early discovery through manufacturing, including novel ADCs designed to target cancer-associated fibroblasts (CAFs), site-specific bioconjugation methods and overcoming challenges in manufacturing. The conference also included a rare session in which Genentech
15th World ADC San Diego 2024
Antibody-drug conjugates are receiving unrivaled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and Astellas’ PADCEV, all alongside a frenzy of companies entering the field and billion-dollar partnerships and M&As from Pfizer, AbbVie, J&J, Merck, Genmab, Ipsen and beyond, ADCs have firmly positioned themselves at the forefront of oncology R&D and dealmaking.
Returning as industry’s definitive ADC forum from early finding to late-phase manufacturing, the 15th World ADC San Diego (November 4-7, 2024 | San Diego, CA) is the world-leading, largest, and most comprehensive ADC-focused conference to maximize the therapeutic window of ADCs. Whether you acquire just ventured into the ADC space or are an ADC guru, you’ll leave this gathering with the insight and connections needed to overcome your challenges and make impactful strides in your work.
Gain exclusive access to the full event guide to view the full agenda with 120+ industry-leading speakers leading 6 end-to-end development content tracks:
- Discovery: Unearth cu
Recognizing the Top Caliber Achievements, Differentiation & Impact to the ADC Community & Patients in Need
The World’s Longest Standing & Definitive ADC Forum
Attendance to the award's gala is complimentary for attendees of the 16th World ADC San Diego. Touted as the most influential event in the industry, this is THE week to fully immerse yourself in all things antibody-drug conjugate, spotlighting the cutting-edge innovation empowering industry to develop differentiated ADCs that show clear advantages against standard of care therapies with clinically meaningful patient benefit.
With 7 streams of end-to-end content, spanning discovery chemistry, discovery biology, preclinical, translational medicine, clinical lessons, process and analytical development, and manufacturing and supply chain: this is your one-stop ADC shop to bring yourself up to speed with the fundamentals, fetch answers to the problems hindering your R&D, and identify emerging trends to ensure you continue ahead of the curve.